

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.80099775 |
| 2 | positive regulation of interferon-alpha production (GO:0032727) | 4.48506851 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.26479778 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.26479778 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.22914765 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.22914765 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.22914765 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.22914765 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.22914765 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.22914765 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 4.21580673 |
| 12 | cellular response to arsenic-containing substance (GO:0071243) | 4.01741262 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.00790418 |
| 14 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.90954833 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.87170370 |
| 16 | response to peptidoglycan (GO:0032494) | 3.81943100 |
| 17 | response to interferon-alpha (GO:0035455) | 3.79186538 |
| 18 | response to interferon-beta (GO:0035456) | 3.75134337 |
| 19 | type I interferon signaling pathway (GO:0060337) | 3.74836406 |
| 20 | cellular response to type I interferon (GO:0071357) | 3.74836406 |
| 21 | response to type I interferon (GO:0034340) | 3.72658516 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.70382282 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57895969 |
| 24 | B cell mediated immunity (GO:0019724) | 3.43444521 |
| 25 | respiratory burst (GO:0045730) | 3.39172049 |
| 26 | cellular response to interferon-beta (GO:0035458) | 3.34845394 |
| 27 | positive regulation of interferon-beta production (GO:0032728) | 3.29040270 |
| 28 | negative regulation of viral genome replication (GO:0045071) | 3.28324474 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.27737414 |
| 30 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.23089369 |
| 31 | regulation of vitamin metabolic process (GO:0030656) | 3.21593945 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 3.16770364 |
| 33 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.14808941 |
| 34 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.12694323 |
| 35 | natural killer cell mediated immunity (GO:0002228) | 3.10230517 |
| 36 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.10230517 |
| 37 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.07396139 |
| 38 | cellular response to exogenous dsRNA (GO:0071360) | 3.06424160 |
| 39 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.01862237 |
| 40 | regulation of chemokine biosynthetic process (GO:0045073) | 3.00403415 |
| 41 | reactive oxygen species biosynthetic process (GO:1903409) | 2.95497725 |
| 42 | regulation of RIG-I signaling pathway (GO:0039535) | 2.95371206 |
| 43 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.94126655 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 2.92909496 |
| 45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91232163 |
| 46 | response to host immune response (GO:0052572) | 2.91232163 |
| 47 | cellular response to virus (GO:0098586) | 2.84303010 |
| 48 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.82570993 |
| 49 | necroptotic process (GO:0070266) | 2.81577548 |
| 50 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80646577 |
| 51 | ribosomal small subunit assembly (GO:0000028) | 2.80573980 |
| 52 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.78845610 |
| 53 | defense response to protozoan (GO:0042832) | 2.77877176 |
| 54 | glycosphingolipid catabolic process (GO:0046479) | 2.76679035 |
| 55 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76611857 |
| 56 | granulocyte activation (GO:0036230) | 2.69289191 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 2.67318970 |
| 58 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.65827446 |
| 59 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.63944023 |
| 60 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.63451168 |
| 61 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.60839622 |
| 62 | response to host (GO:0075136) | 2.60442188 |
| 63 | response to host defenses (GO:0052200) | 2.60442188 |
| 64 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.60442188 |
| 65 | response to protozoan (GO:0001562) | 2.58398849 |
| 66 | regulation of podosome assembly (GO:0071801) | 2.56976714 |
| 67 | cellular response to interferon-alpha (GO:0035457) | 2.55855883 |
| 68 | myeloid cell activation involved in immune response (GO:0002275) | 2.54851857 |
| 69 | glycolipid catabolic process (GO:0019377) | 2.54272812 |
| 70 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.53490000 |
| 71 | neutrophil activation (GO:0042119) | 2.52718680 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 2.52672919 |
| 73 | regulation of interferon-beta production (GO:0032648) | 2.51942349 |
| 74 | T-helper 1 type immune response (GO:0042088) | 2.51409715 |
| 75 | response to arsenic-containing substance (GO:0046685) | 2.50479234 |
| 76 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.48589472 |
| 77 | superoxide anion generation (GO:0042554) | 2.48459990 |
| 78 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.48147796 |
| 79 | cellular response to zinc ion (GO:0071294) | 2.47230866 |
| 80 | regulation of integrin activation (GO:0033623) | 2.47006733 |
| 81 | response to muramyl dipeptide (GO:0032495) | 2.46601534 |
| 82 | negative regulation of growth of symbiont in host (GO:0044130) | 2.45617134 |
| 83 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.45617134 |
| 84 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.45617134 |
| 85 | regulation of growth of symbiont in host (GO:0044126) | 2.45617134 |
| 86 | regulation of chronic inflammatory response (GO:0002676) | 2.44724098 |
| 87 | positive regulation of antigen processing and presentation (GO:0002579) | 2.43639582 |
| 88 | regulation of mast cell degranulation (GO:0043304) | 2.43396505 |
| 89 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.43298983 |
| 90 | programmed necrotic cell death (GO:0097300) | 2.42740976 |
| 91 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.42654504 |
| 92 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.42632745 |
| 93 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.42305443 |
| 94 | leukocyte mediated cytotoxicity (GO:0001909) | 2.42141231 |
| 95 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.40028848 |
| 96 | myeloid dendritic cell activation (GO:0001773) | 2.37552376 |
| 97 | oligosaccharide catabolic process (GO:0009313) | 2.37074399 |
| 98 | T cell migration (GO:0072678) | 2.36911624 |
| 99 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.36751514 |
| 100 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.35853191 |
| 101 | defense response to virus (GO:0051607) | 2.35798216 |
| 102 | cellular response to interferon-gamma (GO:0071346) | 2.35271428 |
| 103 | myeloid dendritic cell differentiation (GO:0043011) | 2.35188840 |
| 104 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.34930001 |
| 105 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.34774052 |
| 106 | response to thyroid hormone (GO:0097066) | 2.33677991 |
| 107 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.31577340 |
| 108 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.31332264 |
| 109 | positive regulation of interleukin-6 production (GO:0032755) | 2.30484229 |
| 110 | pinocytosis (GO:0006907) | 2.28497945 |
| 111 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.28144254 |
| 112 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.28032634 |
| 113 | response to interferon-gamma (GO:0034341) | 2.27439355 |
| 114 | regulation of cholesterol storage (GO:0010885) | 2.27234002 |
| 115 | low-density lipoprotein particle clearance (GO:0034383) | 2.27170883 |
| 116 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.26916370 |
| 117 | positive regulation of type I interferon production (GO:0032481) | 2.26308620 |
| 118 | cellular extravasation (GO:0045123) | 2.26003857 |
| 119 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.25957121 |
| 120 | lymphocyte mediated immunity (GO:0002449) | 2.25175124 |
| 121 | negative regulation of interleukin-12 production (GO:0032695) | 2.24581841 |
| 122 | monocyte chemotaxis (GO:0002548) | 2.24032410 |
| 123 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.24020883 |
| 124 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.23832485 |
| 125 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.23205579 |
| 126 | regulation of hypersensitivity (GO:0002883) | 2.22750606 |
| 127 | positive regulation of chemokine production (GO:0032722) | 2.22576015 |
| 128 | lymphocyte chemotaxis (GO:0048247) | 2.22445496 |
| 129 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.22436068 |
| 130 | lipoxygenase pathway (GO:0019372) | 2.21185866 |
| 131 | regulation of response to interferon-gamma (GO:0060330) | 2.19697516 |
| 132 | hemoglobin metabolic process (GO:0020027) | 2.18748636 |
| 133 | defense response to Gram-positive bacterium (GO:0050830) | 2.18710925 |
| 134 | purine nucleotide salvage (GO:0032261) | 2.17252421 |
| 135 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.17102463 |
| 136 | regulation of leukocyte degranulation (GO:0043300) | 2.16795795 |
| 137 | ceramide catabolic process (GO:0046514) | 2.16578099 |
| 138 | mRNA transcription (GO:0009299) | 2.16248555 |
| 139 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.15489212 |
| 140 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.15296830 |
| 141 | nuclear pore complex assembly (GO:0051292) | 2.15091101 |
| 142 | regulation of interleukin-6 production (GO:0032675) | 2.14680656 |
| 143 | protein localization to endosome (GO:0036010) | 2.14086613 |
| 144 | necrotic cell death (GO:0070265) | 2.13003294 |
| 145 | detection of other organism (GO:0098543) | 2.12858113 |
| 146 | positive regulation of macrophage differentiation (GO:0045651) | 2.12167517 |
| 147 | leukocyte apoptotic process (GO:0071887) | 2.12001851 |
| 148 | GDP-mannose metabolic process (GO:0019673) | 2.11744456 |
| 149 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.11219172 |
| 150 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.10390674 |
| 151 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.10168905 |
| 152 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.08876545 |
| 153 | regulation of interleukin-12 production (GO:0032655) | 2.08488623 |
| 154 | cellular response to lipopolysaccharide (GO:0071222) | 2.07304160 |
| 155 | negative regulation of interleukin-17 production (GO:0032700) | 2.07280848 |
| 156 | germinal center formation (GO:0002467) | 2.07193913 |
| 157 | mature B cell differentiation involved in immune response (GO:0002313) | 2.07161765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.36477859 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.17555958 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.47310315 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.38967911 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.35412887 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75313643 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.69171806 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.67347768 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.48927862 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.48537677 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.48520848 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45703448 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.43891351 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42655774 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.40574186 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.15387477 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.05063250 |
| 18 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00653888 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99934326 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.92748372 |
| 21 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.87009437 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.84792989 |
| 23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.84166853 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80486306 |
| 25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78270018 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72611023 |
| 27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.72175580 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.71732739 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68073056 |
| 30 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67519361 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67058334 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61340879 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60417721 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.60042026 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57666480 |
| 36 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.57166284 |
| 37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.55048234 |
| 38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54743505 |
| 39 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54659190 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54581527 |
| 41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54553978 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54006121 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47249886 |
| 44 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.47018694 |
| 45 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.46376258 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45598160 |
| 47 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.44156717 |
| 48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.44123097 |
| 49 | * MYB_26560356_Chip-Seq_TH2_Human | 1.41870557 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.41764167 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40633775 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37427280 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35491906 |
| 54 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.34805451 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.34613339 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.34301667 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34002643 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32763028 |
| 59 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.31018214 |
| 60 | * MYB_26560356_Chip-Seq_TH1_Human | 1.30853988 |
| 61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30581809 |
| 62 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.29368109 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27879752 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25078185 |
| 65 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24791201 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24626389 |
| 67 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.24597612 |
| 68 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.24582090 |
| 69 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24028988 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22569627 |
| 71 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.22106066 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21903396 |
| 73 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21370303 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18757336 |
| 75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16949903 |
| 76 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.16496031 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.14619459 |
| 78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13855948 |
| 79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13460563 |
| 80 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13060622 |
| 81 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.12801498 |
| 82 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.12766169 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12376768 |
| 84 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.11199861 |
| 85 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.08887641 |
| 86 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08806100 |
| 87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06792099 |
| 88 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.06615796 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05738827 |
| 90 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05687551 |
| 91 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05471668 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05099148 |
| 93 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04447669 |
| 94 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.03830485 |
| 95 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02979293 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02629100 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02045510 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01964851 |
| 99 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00464531 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99242787 |
| 101 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98851031 |
| 102 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.98449074 |
| 103 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.98163460 |
| 104 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98124166 |
| 105 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97219375 |
| 106 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97219375 |
| 107 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.96383842 |
| 108 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.96303118 |
| 109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.94646265 |
| 110 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94587226 |
| 111 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.94432518 |
| 112 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.93812222 |
| 113 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93044827 |
| 114 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.92360777 |
| 115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91988571 |
| 116 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90373429 |
| 117 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.90295644 |
| 118 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.89801679 |
| 119 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89724600 |
| 120 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88774311 |
| 121 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87577720 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 0.87562747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.63145471 |
| 2 | MP0009785_altered_susceptibility_to | 3.33253526 |
| 3 | MP0003436_decreased_susceptibility_to | 3.23259856 |
| 4 | MP0003724_increased_susceptibility_to | 2.94451599 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.64799806 |
| 6 | MP0005025_abnormal_response_to | 2.53544915 |
| 7 | MP0002419_abnormal_innate_immunity | 2.46805748 |
| 8 | MP0006082_CNS_inflammation | 2.42811576 |
| 9 | MP0000685_abnormal_immune_system | 2.42589604 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.38837041 |
| 11 | MP0003303_peritoneal_inflammation | 2.28238045 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.18147073 |
| 13 | MP0001800_abnormal_humoral_immune | 2.15273410 |
| 14 | MP0001790_abnormal_immune_system | 2.07061636 |
| 15 | MP0005387_immune_system_phenotype | 2.07061636 |
| 16 | MP0009840_abnormal_foam_cell | 2.04799486 |
| 17 | MP0002723_abnormal_immune_serum | 2.04614738 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.03148197 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.00730964 |
| 20 | MP0005671_abnormal_response_to | 1.99968686 |
| 21 | MP0001853_heart_inflammation | 1.94325082 |
| 22 | MP0003186_abnormal_redox_activity | 1.92137399 |
| 23 | MP0001545_abnormal_hematopoietic_system | 1.89419364 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.89419364 |
| 25 | MP0009764_decreased_sensitivity_to | 1.82698511 |
| 26 | * MP0001819_abnormal_immune_cell | 1.82292968 |
| 27 | * MP0002420_abnormal_adaptive_immunity | 1.79829624 |
| 28 | MP0002877_abnormal_melanocyte_morpholog | 1.79829599 |
| 29 | MP0005360_urolithiasis | 1.78583779 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.78523343 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.77826300 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.70518758 |
| 33 | MP0008469_abnormal_protein_level | 1.69159932 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.65812165 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.65084791 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.64000498 |
| 37 | MP0004947_skin_inflammation | 1.63190213 |
| 38 | MP0002006_tumorigenesis | 1.62984430 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.59433395 |
| 40 | MP0010307_abnormal_tumor_latency | 1.57363150 |
| 41 | * MP0002398_abnormal_bone_marrow | 1.52771041 |
| 42 | MP0002405_respiratory_system_inflammati | 1.52543289 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.49191970 |
| 44 | MP0009278_abnormal_bone_marrow | 1.48813336 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.47107306 |
| 46 | * MP0000716_abnormal_immune_system | 1.46792491 |
| 47 | MP0008260_abnormal_autophagy | 1.46388086 |
| 48 | MP0003693_abnormal_embryo_hatching | 1.46014925 |
| 49 | MP0000343_altered_response_to | 1.46006661 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.44675488 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.41981889 |
| 52 | MP0003448_altered_tumor_morphology | 1.41346207 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.41310767 |
| 54 | MP0000858_altered_metastatic_potential | 1.41036825 |
| 55 | * MP0002429_abnormal_blood_cell | 1.32670089 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.31885462 |
| 57 | MP0003828_pulmonary_edema | 1.29136256 |
| 58 | MP0000490_abnormal_crypts_of | 1.29073332 |
| 59 | * MP0002722_abnormal_immune_system | 1.28369258 |
| 60 | MP0006054_spinal_hemorrhage | 1.27859622 |
| 61 | MP0005310_abnormal_salivary_gland | 1.27107004 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.26668715 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.26657476 |
| 64 | MP0008004_abnormal_stomach_pH | 1.25484622 |
| 65 | MP0003075_altered_response_to | 1.21929452 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 1.20821743 |
| 67 | MP0005076_abnormal_cell_differentiation | 1.16441171 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.15261538 |
| 69 | MP0002796_impaired_skin_barrier | 1.15145627 |
| 70 | MP0009763_increased_sensitivity_to | 1.13100960 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.11053237 |
| 72 | MP0002254_reproductive_system_inflammat | 1.07151285 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.05960702 |
| 74 | MP0004147_increased_porphyrin_level | 1.05799957 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.02847999 |
| 76 | MP0005166_decreased_susceptibility_to | 1.01299392 |
| 77 | MP0005501_abnormal_skin_physiology | 1.00869145 |
| 78 | MP0005164_abnormal_response_to | 1.00044344 |
| 79 | MP0004510_myositis | 0.99932971 |
| 80 | MP0010094_abnormal_chromosome_stability | 0.99566742 |
| 81 | MP0001216_abnormal_epidermal_layer | 0.99417726 |
| 82 | * MP0000703_abnormal_thymus_morphology | 0.97793393 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 0.97724715 |
| 84 | MP0000609_abnormal_liver_physiology | 0.96868344 |
| 85 | MP0005085_abnormal_gallbladder_physiolo | 0.96417212 |
| 86 | MP0003786_premature_aging | 0.96206560 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.95587485 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.95491725 |
| 89 | MP0003077_abnormal_cell_cycle | 0.94950217 |
| 90 | MP0008438_abnormal_cutaneous_collagen | 0.94682053 |
| 91 | MP0005023_abnormal_wound_healing | 0.93233428 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.92985419 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91356475 |
| 94 | MP0008057_abnormal_DNA_replication | 0.90827125 |
| 95 | MP0008007_abnormal_cellular_replicative | 0.89529573 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.89172908 |
| 97 | MP0005083_abnormal_biliary_tract | 0.88620200 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.88568250 |
| 99 | MP0003705_abnormal_hypodermis_morpholog | 0.87890760 |
| 100 | MP0000598_abnormal_liver_morphology | 0.87816858 |
| 101 | MP0001851_eye_inflammation | 0.87648964 |
| 102 | MP0005165_increased_susceptibility_to | 0.87177728 |
| 103 | MP0005451_abnormal_body_composition | 0.85531242 |
| 104 | MP0005390_skeleton_phenotype | 0.84036344 |
| 105 | MP0005365_abnormal_bile_salt | 0.83116287 |
| 106 | * MP0003763_abnormal_thymus_physiology | 0.83050578 |
| 107 | MP0002138_abnormal_hepatobiliary_system | 0.82782484 |
| 108 | MP0000313_abnormal_cell_death | 0.80517563 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 0.80422139 |
| 110 | MP0004264_abnormal_extraembryonic_tissu | 0.80311964 |
| 111 | MP0001849_ear_inflammation | 0.80010628 |
| 112 | MP0000249_abnormal_blood_vessel | 0.79908683 |
| 113 | MP0009931_abnormal_skin_appearance | 0.78886865 |
| 114 | MP0004957_abnormal_blastocyst_morpholog | 0.78073374 |
| 115 | MP0003111_abnormal_nucleus_morphology | 0.77779689 |
| 116 | MP0003195_calcinosis | 0.76852525 |
| 117 | MP0010329_abnormal_lipoprotein_level | 0.76066963 |
| 118 | MP0001873_stomach_inflammation | 0.73358175 |
| 119 | * MP0002136_abnormal_kidney_physiology | 0.72978594 |
| 120 | MP0001764_abnormal_homeostasis | 0.72591342 |
| 121 | * MP0009643_abnormal_urine_homeostasis | 0.70749632 |
| 122 | MP0000604_amyloidosis | 0.70686266 |
| 123 | MP0008873_increased_physiological_sensi | 0.69286343 |
| 124 | MP0002933_joint_inflammation | 0.67385507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.18704682 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.99961721 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.99101384 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.78958808 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.37840261 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.06327583 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.06327583 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.06327583 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.94417562 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.81196234 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.63327555 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.36466739 |
| 13 | Myositis (HP:0100614) | 3.30392777 |
| 14 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.25848821 |
| 15 | Thrombocytosis (HP:0001894) | 3.23825273 |
| 16 | Recurrent skin infections (HP:0001581) | 3.19476140 |
| 17 | Cellulitis (HP:0100658) | 3.19412739 |
| 18 | Petechiae (HP:0000967) | 3.18348398 |
| 19 | Chronic otitis media (HP:0000389) | 3.06291943 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 3.00500350 |
| 21 | Basal ganglia calcification (HP:0002135) | 2.97191933 |
| 22 | Recurrent fungal infections (HP:0002841) | 2.96381343 |
| 23 | Stomatitis (HP:0010280) | 2.80594387 |
| 24 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.75725971 |
| 25 | Poor head control (HP:0002421) | 2.74693617 |
| 26 | Nausea (HP:0002018) | 2.73454577 |
| 27 | Gingival bleeding (HP:0000225) | 2.73020169 |
| 28 | Orchitis (HP:0100796) | 2.72035204 |
| 29 | Urticaria (HP:0001025) | 2.70831801 |
| 30 | Gingivitis (HP:0000230) | 2.69047850 |
| 31 | * Recurrent viral infections (HP:0004429) | 2.64863897 |
| 32 | Pustule (HP:0200039) | 2.63450978 |
| 33 | Joint hemorrhage (HP:0005261) | 2.61300827 |
| 34 | Loss of speech (HP:0002371) | 2.59777426 |
| 35 | Prostate neoplasm (HP:0100787) | 2.59613592 |
| 36 | Paralysis (HP:0003470) | 2.59213820 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.58087418 |
| 38 | * Vasculitis (HP:0002633) | 2.54907844 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.54788774 |
| 40 | Obstructive lung disease (HP:0006536) | 2.54788774 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.54582060 |
| 42 | Periodontitis (HP:0000704) | 2.52169249 |
| 43 | Glomerulonephritis (HP:0000099) | 2.52144302 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.50971240 |
| 45 | Increased serum ferritin (HP:0003281) | 2.48768068 |
| 46 | IgM deficiency (HP:0002850) | 2.45995848 |
| 47 | Purpura (HP:0000979) | 2.44196030 |
| 48 | Myocardial infarction (HP:0001658) | 2.42552116 |
| 49 | Epistaxis (HP:0000421) | 2.39648307 |
| 50 | Meningitis (HP:0001287) | 2.37794484 |
| 51 | Osteomyelitis (HP:0002754) | 2.37655026 |
| 52 | Rough bone trabeculation (HP:0100670) | 2.35430973 |
| 53 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.34916561 |
| 54 | Oral leukoplakia (HP:0002745) | 2.34754683 |
| 55 | Polycythemia (HP:0001901) | 2.33659019 |
| 56 | Axonal loss (HP:0003447) | 2.33496620 |
| 57 | Abnormality of the prostate (HP:0008775) | 2.32940045 |
| 58 | Increased IgM level (HP:0003496) | 2.31692644 |
| 59 | Abnormality of iron homeostasis (HP:0011031) | 2.31569972 |
| 60 | Agnosia (HP:0010524) | 2.28909787 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.26340485 |
| 62 | Complement deficiency (HP:0004431) | 2.25886803 |
| 63 | * Autoimmune thrombocytopenia (HP:0001973) | 2.25145453 |
| 64 | Recurrent pneumonia (HP:0006532) | 2.23469390 |
| 65 | Increased IgE level (HP:0003212) | 2.21529293 |
| 66 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.20538743 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.19855055 |
| 68 | Hypertensive crisis (HP:0100735) | 2.19788045 |
| 69 | Thick nail (HP:0001805) | 2.19492384 |
| 70 | Recurrent bronchitis (HP:0002837) | 2.19095757 |
| 71 | Progressive external ophthalmoplegia (HP:0000590) | 2.18965843 |
| 72 | Abnormal number of erythroid precursors (HP:0012131) | 2.17776117 |
| 73 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.16251062 |
| 74 | Conjunctival telangiectasia (HP:0000524) | 2.15681821 |
| 75 | Abnormality of complement system (HP:0005339) | 2.14261262 |
| 76 | Poikilocytosis (HP:0004447) | 2.12751819 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 2.12183736 |
| 78 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.12107830 |
| 79 | Reticulocytopenia (HP:0001896) | 2.11665129 |
| 80 | Abnormal trabecular bone morphology (HP:0100671) | 2.11421149 |
| 81 | Hepatosplenomegaly (HP:0001433) | 2.10487149 |
| 82 | Abnormality of the nasal mucosa (HP:0000433) | 2.10108577 |
| 83 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.06061613 |
| 84 | Keratoconjunctivitis sicca (HP:0001097) | 2.05686186 |
| 85 | Retrobulbar optic neuritis (HP:0100654) | 2.05185782 |
| 86 | Optic neuritis (HP:0100653) | 2.05185782 |
| 87 | Hematochezia (HP:0002573) | 2.05114255 |
| 88 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.05005576 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04146667 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04146667 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.03894418 |
| 92 | Leukocytosis (HP:0001974) | 2.03563526 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03309869 |
| 94 | Amyloidosis (HP:0011034) | 2.03233490 |
| 95 | Abnormality of nail color (HP:0100643) | 2.02869626 |
| 96 | Impaired platelet aggregation (HP:0003540) | 2.02716612 |
| 97 | Abnormal platelet function (HP:0011869) | 2.02716612 |
| 98 | Nasal polyposis (HP:0100582) | 2.00718223 |
| 99 | Skin ulcer (HP:0200042) | 1.99948745 |
| 100 | Spontaneous hematomas (HP:0007420) | 1.99414185 |
| 101 | Arterial thrombosis (HP:0004420) | 1.99389859 |
| 102 | Esophageal neoplasm (HP:0100751) | 1.99363736 |
| 103 | Neoplasm of head and neck (HP:0012288) | 1.99363736 |
| 104 | Reticulocytosis (HP:0001923) | 1.99106553 |
| 105 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97538465 |
| 106 | Osteolytic defects of the hand bones (HP:0009699) | 1.97538465 |
| 107 | Nephritis (HP:0000123) | 1.96440321 |
| 108 | Aplastic anemia (HP:0001915) | 1.94120986 |
| 109 | Peritonitis (HP:0002586) | 1.93580180 |
| 110 | Anorexia (HP:0002039) | 1.93450451 |
| 111 | Microcytic anemia (HP:0001935) | 1.92906953 |
| 112 | Pallor (HP:0000980) | 1.92887652 |
| 113 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.92431381 |
| 114 | Pulmonary infiltrates (HP:0002113) | 1.91903048 |
| 115 | Vertebral compression fractures (HP:0002953) | 1.90881783 |
| 116 | Disinhibition (HP:0000734) | 1.90742399 |
| 117 | T lymphocytopenia (HP:0005403) | 1.88851482 |
| 118 | Esophageal varix (HP:0002040) | 1.86887961 |
| 119 | Xanthomatosis (HP:0000991) | 1.86476513 |
| 120 | Erythema (HP:0010783) | 1.85771403 |
| 121 | Thrombophlebitis (HP:0004418) | 1.85488111 |
| 122 | Abnormal platelet volume (HP:0011876) | 1.84510631 |
| 123 | Gangrene (HP:0100758) | 1.84250845 |
| 124 | * Recurrent lower respiratory tract infections (HP:0002783) | 1.84168316 |
| 125 | * Abnormality of T cell physiology (HP:0011840) | 1.83655405 |
| 126 | Fatigue (HP:0012378) | 1.80038664 |
| 127 | IgA deficiency (HP:0002720) | 1.79410517 |
| 128 | Abnormality of reticulocytes (HP:0004312) | 1.78784341 |
| 129 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78687855 |
| 130 | Mucopolysacchariduria (HP:0008155) | 1.78687855 |
| 131 | Eosinophilia (HP:0001880) | 1.78508144 |
| 132 | Granulocytopenia (HP:0001913) | 1.78410481 |
| 133 | Squamous cell carcinoma (HP:0002860) | 1.78311048 |
| 134 | Reduced antithrombin III activity (HP:0001976) | 1.76656615 |
| 135 | Cholecystitis (HP:0001082) | 1.76208431 |
| 136 | Abnormal gallbladder physiology (HP:0012438) | 1.76208431 |
| 137 | Cholelithiasis (HP:0001081) | 1.75467407 |
| 138 | Abnormality of T cell number (HP:0011839) | 1.75236304 |
| 139 | Encephalitis (HP:0002383) | 1.75130333 |
| 140 | Mucosal telangiectasiae (HP:0100579) | 1.75078931 |
| 141 | Abnormal blistering of the skin (HP:0008066) | 1.73460653 |
| 142 | Skin rash (HP:0000988) | 1.72925918 |
| 143 | * Autoimmune hemolytic anemia (HP:0001890) | 1.72334789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TBK1 | 3.02259358 |
| 2 | ERN1 | 2.96873937 |
| 3 | TYK2 | 2.95959841 |
| 4 | NME2 | 2.80087353 |
| 5 | MAP3K14 | 2.64894555 |
| 6 | PBK | 2.62550675 |
| 7 | MAP4K1 | 2.60733996 |
| 8 | PRPF4B | 2.60448399 |
| 9 | BLK | 2.57500382 |
| 10 | TAOK2 | 2.40771748 |
| 11 | IKBKE | 2.38334850 |
| 12 | IRAK3 | 2.30211520 |
| 13 | PIM2 | 2.29386166 |
| 14 | IRAK4 | 2.26057047 |
| 15 | JAK3 | 2.20701984 |
| 16 | KIT | 2.09190617 |
| 17 | RPS6KA4 | 1.83117514 |
| 18 | IKBKB | 1.82299552 |
| 19 | ZAP70 | 1.64681977 |
| 20 | RIPK4 | 1.52727104 |
| 21 | MAP2K3 | 1.49535381 |
| 22 | TGFBR2 | 1.42850154 |
| 23 | STK10 | 1.42431389 |
| 24 | TIE1 | 1.40599142 |
| 25 | WEE1 | 1.40035232 |
| 26 | SMG1 | 1.37826905 |
| 27 | EIF2AK1 | 1.37667233 |
| 28 | PIM1 | 1.37602977 |
| 29 | MAP3K10 | 1.37359378 |
| 30 | BMPR2 | 1.35891565 |
| 31 | NEK9 | 1.34310312 |
| 32 | BTK | 1.33599334 |
| 33 | JAK1 | 1.33131013 |
| 34 | CSF1R | 1.31284085 |
| 35 | TEC | 1.30906095 |
| 36 | STK4 | 1.30570842 |
| 37 | FLT3 | 1.30195957 |
| 38 | KDR | 1.28962418 |
| 39 | NEK1 | 1.28861686 |
| 40 | TGFBR1 | 1.28715157 |
| 41 | ACVR1B | 1.27324215 |
| 42 | CDK12 | 1.26909436 |
| 43 | EEF2K | 1.23161688 |
| 44 | TAOK1 | 1.22825803 |
| 45 | FGFR4 | 1.20936445 |
| 46 | TAOK3 | 1.18917055 |
| 47 | MOS | 1.18541347 |
| 48 | TXK | 1.18387289 |
| 49 | SYK | 1.18369198 |
| 50 | MAP3K1 | 1.14533758 |
| 51 | EPHA2 | 1.13497218 |
| 52 | NEK2 | 1.12118450 |
| 53 | STK24 | 1.11313101 |
| 54 | LRRK2 | 1.09367414 |
| 55 | CSK | 1.06176159 |
| 56 | ABL2 | 1.00894909 |
| 57 | PKN2 | 1.00635856 |
| 58 | LYN | 1.00569397 |
| 59 | CHUK | 1.00006554 |
| 60 | MAP3K11 | 0.99435742 |
| 61 | FGR | 0.97756228 |
| 62 | BUB1 | 0.96881268 |
| 63 | MATK | 0.96209111 |
| 64 | CLK1 | 0.95250280 |
| 65 | TSSK6 | 0.94615093 |
| 66 | MST4 | 0.92553420 |
| 67 | GRK7 | 0.91373427 |
| 68 | CDK4 | 0.91232089 |
| 69 | PDK2 | 0.90350095 |
| 70 | JAK2 | 0.88819912 |
| 71 | EIF2AK2 | 0.86780528 |
| 72 | HCK | 0.85260595 |
| 73 | BMX | 0.84928592 |
| 74 | CDC7 | 0.83802919 |
| 75 | IRAK2 | 0.82081672 |
| 76 | LCK | 0.81888040 |
| 77 | EIF2AK3 | 0.81031704 |
| 78 | SCYL2 | 0.77897330 |
| 79 | MAPKAPK3 | 0.77522071 |
| 80 | SIK3 | 0.77292323 |
| 81 | MAP3K8 | 0.76363220 |
| 82 | MST1R | 0.75500771 |
| 83 | BCKDK | 0.74423656 |
| 84 | MAP3K13 | 0.71002248 |
| 85 | CDK6 | 0.69908696 |
| 86 | MAP3K5 | 0.68552428 |
| 87 | RPS6KB2 | 0.68059079 |
| 88 | FGFR3 | 0.67708970 |
| 89 | STK16 | 0.67561469 |
| 90 | STK3 | 0.66113536 |
| 91 | ATR | 0.65656283 |
| 92 | MAPK11 | 0.64733071 |
| 93 | MAP3K3 | 0.63660954 |
| 94 | VRK1 | 0.63032129 |
| 95 | MAP3K12 | 0.62749236 |
| 96 | MARK3 | 0.59347354 |
| 97 | BRAF | 0.59004397 |
| 98 | DYRK3 | 0.58512191 |
| 99 | BRSK2 | 0.57508279 |
| 100 | ARAF | 0.57159921 |
| 101 | ITK | 0.56254246 |
| 102 | CDK7 | 0.55614834 |
| 103 | EPHB1 | 0.54079151 |
| 104 | PAK4 | 0.52605352 |
| 105 | SRPK1 | 0.52450443 |
| 106 | MAPK4 | 0.51598245 |
| 107 | CHEK2 | 0.51483122 |
| 108 | AURKB | 0.50672365 |
| 109 | NLK | 0.50359130 |
| 110 | TRPM7 | 0.50353351 |
| 111 | TESK2 | 0.49889054 |
| 112 | PIK3CG | 0.49814343 |
| 113 | TTK | 0.49642705 |
| 114 | RIPK1 | 0.48766309 |
| 115 | TRIB3 | 0.47864171 |
| 116 | ABL1 | 0.47788805 |
| 117 | GRK6 | 0.47288360 |
| 118 | PRKCD | 0.45575533 |
| 119 | AURKA | 0.45509945 |
| 120 | MAPKAPK2 | 0.43339033 |
| 121 | TLK1 | 0.41618040 |
| 122 | FES | 0.41564746 |
| 123 | EGFR | 0.39477499 |
| 124 | RPS6KA5 | 0.39219235 |
| 125 | PRKG2 | 0.38857245 |
| 126 | IRAK1 | 0.38097746 |
| 127 | ICK | 0.38084608 |
| 128 | GSK3A | 0.36357521 |
| 129 | LATS2 | 0.32458134 |
| 130 | DAPK1 | 0.32337353 |
| 131 | PAK1 | 0.31911219 |
| 132 | PDPK1 | 0.30723591 |
| 133 | CHEK1 | 0.30112795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.84593895 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.71865050 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64101245 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.28190611 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.22993462 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.17918962 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.04364068 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.03619222 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.93218524 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.85402291 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.84890270 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.78117188 |
| 13 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75406743 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.67477854 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.63588334 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.63472159 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.58865362 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.57207760 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.56479240 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55811475 |
| 21 | Proteasome_Homo sapiens_hsa03050 | 1.54176411 |
| 22 | Bladder cancer_Homo sapiens_hsa05219 | 1.52110736 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50381928 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.42525263 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.39902907 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 1.39397995 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.37565216 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36671403 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.36450160 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35783316 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34294449 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.29402710 |
| 33 | Base excision repair_Homo sapiens_hsa03410 | 1.25566270 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.24233993 |
| 35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.22309550 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.21478734 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19806240 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18426260 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.15662010 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15293521 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12898284 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10140759 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05990537 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05666352 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.04767201 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.04219450 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04165328 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03645720 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 1.03013014 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02898187 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01573573 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.01393299 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99804749 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.97109391 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96649106 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95972446 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95280157 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94275125 |
| 59 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.92614921 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92318970 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.91122231 |
| 62 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.89783036 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 0.89742657 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.86661895 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84572430 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83071255 |
| 67 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81643709 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81462735 |
| 69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81039100 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80450270 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79071005 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78472005 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.77943302 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.77348685 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.77089195 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76322479 |
| 77 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.75114148 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72492848 |
| 79 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.72454762 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72091800 |
| 81 | RNA transport_Homo sapiens_hsa03013 | 0.71580845 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.68285659 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67144473 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65905316 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65556928 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64339643 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63942970 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63792300 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61072554 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60428649 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59710617 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59529366 |
| 93 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57404773 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56580799 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56571029 |
| 96 | Cell cycle_Homo sapiens_hsa04110 | 0.56497010 |
| 97 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56142081 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54631919 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53547742 |
| 100 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53359344 |
| 101 | Spliceosome_Homo sapiens_hsa03040 | 0.53151844 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52632679 |
| 103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52068962 |
| 104 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51311241 |
| 105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50816593 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49604836 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49064001 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48259704 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.47120308 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.46693539 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45871782 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44580825 |
| 113 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43413333 |
| 114 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.43263874 |
| 115 | RNA polymerase_Homo sapiens_hsa03020 | 0.42702384 |
| 116 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42621818 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42195763 |
| 118 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41906497 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41463574 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41400671 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.41310776 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40742718 |
| 123 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40171332 |

